Pregled bibliografske jedinice broj: 1103722
Dyslipidaemia, a factor worthy of adjustment
Dyslipidaemia, a factor worthy of adjustment // European Journal of Heart Failure, 22 (2019), 3; 564-564 doi:10.1002/ejhf.1647 (međunarodna recenzija, pismo uredniku, znanstveni)
CROSBI ID: 1103722 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Dyslipidaemia, a factor worthy of adjustment
Autori
Skelin, Marko ; Lucijanic, Marko ; Lucijanic, Jelena
Izvornik
European Journal of Heart Failure (1388-9842) 22
(2019), 3;
564-564
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, znanstveni
Ključne riječi
type 2 diabetes mellitus ; dyslipidaemia
Sažetak
Recently, were documented detrimental effects of type 2 diabetes mellitus (T2DM) and insulin on mortality and hospitalizations due to heart failure in patients with heart failure with preserved ejection fraction (HFpEF). Although, authors have made multiple adjustments when performing Cox regression analysis, they did not make adjustments for dyslipidaemia whose regulation is a cornerstone of treatment in secondary prevention of cardiovascular disease due to its beneficial effects, including mortality. Considering, substantial number of patients in this study that would benefit from the regulation of dyslipidaemia, we believe that additional adjustments of Cox regression models for baseline dyslipidaemia prevalence and history of CABG/PCI would enhance robustness of the study results.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Opća bolnica Šibenik,
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE